Company Senesco Technologies, Inc. Nyse
Equities
US8172084084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 31/10/20 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 07/09/21 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 30/04/14 |
Alan Walts
BRD | Director/Board Member | 64 | 31/03/21 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 31/03/21 |
Lindsay Androski
BRD | Director/Board Member | - | 04/07/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- ELOX Stock
- Stock
- Company Senesco Technologies, Inc.